Markers of endothelial glycocalyx dysfunction in Clarkson disease.

Autor: Xie Z; Lung and Vascular Inflammation Section, Laboratory of Allergic Diseases, National, Institute of Allergy and Infectious Diseases/National Institutes of Health, (NIAID/NIH), 10 Center Drive, Room 11N238A, Bethesda, MD, 20892, USA., Børset M; Department of Clinical and Molecular Medicine, Norwegian University of Science and Technology, Trondheim, Norway.; Department of Immunology and Transfusion Medicine, St. Olav's University, Hospital, Trondheim, Norway., Svéen K; Department of Clinical and Molecular Medicine, Norwegian University of Science and Technology, Trondheim, Norway., Bøe OW; Department of Clinical and Molecular Medicine, Norwegian University of Science and Technology, Trondheim, Norway., Chan EC; Lung and Vascular Inflammation Section, Laboratory of Allergic Diseases, National, Institute of Allergy and Infectious Diseases/National Institutes of Health, (NIAID/NIH), 10 Center Drive, Room 11N238A, Bethesda, MD, 20892, USA., Lack JB; NIAID Collaborative Bioinformatics Resource, NIAID/NIH, Health, Bethesda, MD, 20892, USA., Hornick KM; NIAID Collaborative Bioinformatics Resource, NIAID/NIH, Health, Bethesda, MD, 20892, USA., Verlicchi F; Transfusion Medicine Faenza-Lugo, Transfusion Service Ravenna, Romagna Health Unit, Ravenna, Italy., Eisch AR; Lung and Vascular Inflammation Section, Laboratory of Allergic Diseases, National, Institute of Allergy and Infectious Diseases/National Institutes of Health, (NIAID/NIH), 10 Center Drive, Room 11N238A, Bethesda, MD, 20892, USA., Melchio R; Department of Internal Medicine, Santa Croce E Carle' Hospital, Via Michele Coppino 26, Cuneo, Italy., Dudek AZ; HealthPartners Neuroscience Center, St. Paul, MN, USA., Druey KM; Lung and Vascular Inflammation Section, Laboratory of Allergic Diseases, National, Institute of Allergy and Infectious Diseases/National Institutes of Health, (NIAID/NIH), 10 Center Drive, Room 11N238A, Bethesda, MD, 20892, USA. kdruey@niaid.nih.gov.

Publikováno v: Journal of translational medicine [J Transl Med] 2022 Aug 29; Vol. 20 (1), pp. 380. Date of Electronic Publication: 2022 Aug 29.

Phosphatases of regenerating liver are key regulators of metabolism in cancer cells - role of Serine/Glycine metabolism.

Autor: Abdollahi P; Center for Myeloma Research, Department of Clinical and Molecular Medicine, Faculty of Medicine and Health Sciences, Norwegian University of Science and Technology (NTNU).; Laboratory Clinic., Vandsemb EN; Center for Myeloma Research, Department of Clinical and Molecular Medicine, Faculty of Medicine and Health Sciences, Norwegian University of Science and Technology (NTNU)., Børset M; Center for Myeloma Research, Department of Clinical and Molecular Medicine, Faculty of Medicine and Health Sciences, Norwegian University of Science and Technology (NTNU).; Department of Immunology and Transfusion Medicine, St. Olavs hospital, Trondheim University Hospital, Trondheim, Norway.

Publikováno v: Current opinion in clinical nutrition and metabolic care [Curr Opin Clin Nutr Metab Care] 2022 Jan 01; Vol. 25 (1), pp. 50-55.

PRL-3 induces a positive signaling circuit between glycolysis and activation of STAT1/2.

Autor: Vandsemb EN; Department of Clinical and Molecular Medicine, Faculty of Medicine and Health Sciences, Norwegian University of Science and Technology (NTNU), Trondheim, Norway., Rye MB; Department of Clinical and Molecular Medicine, Faculty of Medicine and Health Sciences, Norwegian University of Science and Technology (NTNU), Trondheim, Norway.; Clinic of Surgery, St. Olavs University Hospital, Trondheim, Norway.; Clinic of Laboratory Medicine, St. Olavs University Hospital, Trondheim, Norway.; Biocore - Bioinformatics Core Facility, Norwegian University of Science and Technology (NTNU), Trondheim, Norway., Steiro IJ; Department of Clinical and Molecular Medicine, Faculty of Medicine and Health Sciences, Norwegian University of Science and Technology (NTNU), Trondheim, Norway., Elsaadi S; Department of Clinical and Molecular Medicine, Faculty of Medicine and Health Sciences, Norwegian University of Science and Technology (NTNU), Trondheim, Norway.; Clinic of Laboratory Medicine, St. Olavs University Hospital, Trondheim, Norway., Rø TB; Department of Clinical and Molecular Medicine, Faculty of Medicine and Health Sciences, Norwegian University of Science and Technology (NTNU), Trondheim, Norway.; Children's Clinic, St. Olavs University Hospital, Trondheim, Norway., Slørdahl TS; Department of Clinical and Molecular Medicine, Faculty of Medicine and Health Sciences, Norwegian University of Science and Technology (NTNU), Trondheim, Norway.; Clinic of Medicine, St. Olavs University Hospital, Trondheim, Norway., Sponaas AM; Department of Clinical and Molecular Medicine, Faculty of Medicine and Health Sciences, Norwegian University of Science and Technology (NTNU), Trondheim, Norway., Børset M; Department of Clinical and Molecular Medicine, Faculty of Medicine and Health Sciences, Norwegian University of Science and Technology (NTNU), Trondheim, Norway.; Department of Immunology and Transfusion Medicine, St. Olavs University Hospital, Norway., Abdollahi P; Department of Clinical and Molecular Medicine, Faculty of Medicine and Health Sciences, Norwegian University of Science and Technology (NTNU), Trondheim, Norway.; Clinic of Laboratory Medicine, St. Olavs University Hospital, Trondheim, Norway.; Clinic of Medicine, St. Olavs University Hospital, Trondheim, Norway.

Publikováno v: The FEBS journal [FEBS J] 2021 Dec; Vol. 288 (23), pp. 6700-6715. Date of Electronic Publication: 2021 Jun 20.

Analysis of Intra-Tumoral Macrophages and T Cells in Non-Small Cell Lung Cancer (NSCLC) Indicates a Role for Immune Checkpoint and CD200-CD200R Interactions.

Autor: Tøndell A; Department of Thoracic Medicine, St. Olavs Hospital, Trondheim University Hospital, 7006 Trondheim, Norway.; Department of Clinical and Molecular Medicine, Norwegian University of Science and Technology, 7491 Trondheim, Norway., Subbannayya Y; Department of Clinical and Molecular Medicine, Norwegian University of Science and Technology, 7491 Trondheim, Norway.; Centre of Molecular Inflammation Research, Norwegian University of Science and Technology, 7491 Trondheim, Norway., Wahl SGF; Department of Clinical and Molecular Medicine, Norwegian University of Science and Technology, 7491 Trondheim, Norway.; Department of Pathology, St. Olavs Hospital, Trondheim University Hospital, 7006 Trondheim, Norway., Flatberg A; Department of Clinical and Molecular Medicine, Norwegian University of Science and Technology, 7491 Trondheim, Norway.; Central Administration, St. Olavs Hospital, Trondheim University Hospital, 7006 Trondheim, Norway., Sørhaug S; Department of Thoracic Medicine, St. Olavs Hospital, Trondheim University Hospital, 7006 Trondheim, Norway., Børset M; Department of Clinical and Molecular Medicine, Norwegian University of Science and Technology, 7491 Trondheim, Norway.; Department of Immunology and Transfusion Medicine, St. Olavs Hospital, Trondheim University Hospital, 7006 Trondheim, Norway., Haug M; Department of Clinical and Molecular Medicine, Norwegian University of Science and Technology, 7491 Trondheim, Norway.; Centre of Molecular Inflammation Research, Norwegian University of Science and Technology, 7491 Trondheim, Norway.; Department of Infectious Diseases, St. Olavs Hospital, Trondheim University Hospital, 7006 Trondheim, Norway.

Publikováno v: Cancers [Cancers (Basel)] 2021 Apr 09; Vol. 13 (8). Date of Electronic Publication: 2021 Apr 09.

Phosphatase of regenerating liver-3 regulates cancer cell metabolism in multiple myeloma.

Autor: Abdollahi P; Department of Clinical and Molecular Medicine, Faculty of Medicine and Health Sciences, Norwegian University of Science and Technology, Trondheim, Norway.; Laboratory Clinic, St. Olavs University Hospital, Trondheim, Norway., Vandsemb EN; Department of Clinical and Molecular Medicine, Faculty of Medicine and Health Sciences, Norwegian University of Science and Technology, Trondheim, Norway., Elsaadi S; Department of Clinical and Molecular Medicine, Faculty of Medicine and Health Sciences, Norwegian University of Science and Technology, Trondheim, Norway., Røst LM; Department of Biotechnology and Food Science, Faculty of Natural Sciences, Norwegian University of Science and Technology, Trondheim, Norway., Yang R; Department of Clinical and Molecular Medicine, Faculty of Medicine and Health Sciences, Norwegian University of Science and Technology, Trondheim, Norway.; Laboratory Clinic, St. Olavs University Hospital, Trondheim, Norway., Hjort MA; Department of Clinical and Molecular Medicine, Faculty of Medicine and Health Sciences, Norwegian University of Science and Technology, Trondheim, Norway.; Children's Clinic, St. Olavs University Hospital, Trondheim, Norway., Andreassen T; MR Core Facility, Department of Circulation and Medical Imaging, Faculty of Medicine and Health Sciences, Norwegian University of Science and Technology, Trondheim, Norway., Misund K; Department of Clinical and Molecular Medicine, Faculty of Medicine and Health Sciences, Norwegian University of Science and Technology, Trondheim, Norway.; Clinic of Medicine, St. Olavs University Hospital, Trondheim, Norway., Slørdahl TS; Department of Clinical and Molecular Medicine, Faculty of Medicine and Health Sciences, Norwegian University of Science and Technology, Trondheim, Norway.; Clinic of Medicine, St. Olavs University Hospital, Trondheim, Norway., Rø TB; Department of Clinical and Molecular Medicine, Faculty of Medicine and Health Sciences, Norwegian University of Science and Technology, Trondheim, Norway.; Children's Clinic, St. Olavs University Hospital, Trondheim, Norway., Sponaas AM; Department of Clinical and Molecular Medicine, Faculty of Medicine and Health Sciences, Norwegian University of Science and Technology, Trondheim, Norway., Moestue S; Department of Clinical and Molecular Medicine, Faculty of Medicine and Health Sciences, Norwegian University of Science and Technology, Trondheim, Norway.; Department of Pharmacy, Faculty of Health Sciences, Nord University, Bodø, Norway., Bruheim P; Department of Biotechnology and Food Science, Faculty of Natural Sciences, Norwegian University of Science and Technology, Trondheim, Norway., Børset M; Department of Clinical and Molecular Medicine, Faculty of Medicine and Health Sciences, Norwegian University of Science and Technology, Trondheim, Norway.; Department of Immunology and Transfusion Medicine, St. Olavs University Hospital, Trondheim, Norway.

Publikováno v: FASEB journal : official publication of the Federation of American Societies for Experimental Biology [FASEB J] 2021 Mar; Vol. 35 (3), pp. e21344.